Cheryl Teruya, Ph.D.

ISAP Researchers' Profiles

Cheryl Teruya, Ph.D.

Cheryl Teruya, Ph.D., is currently Principal Investigator for “Exploring Proposition 36 as a Turning Point in Life Course Drug Use Trajectories” (NIDA) and Project Director for “Retention of Suboxone Patients in START: Perspectives of Providers and Patients” (NIDA) and “Drum-assisted Recovery Therapy for Native Americans” (NCCAM). She also serves as the Coordinator for the NIDA-funded Center for Advancing Longitudinal Drug Abuse Research (CALDAR) at the UCLA Integrated Substance Abuse Programs (ISAP). Previously, Dr. Teruya was Co-Principal Investigator for a study examining treatment motivation among drug users and has directed studies investigating treatment providers’ readiness for implementing research into practice and the impact of California’s Proposition 36 on the drug treatment system. In addition, she led the qualitative study for the California Treatment Outcome Project (CalTOP), conducting and analyzing data from over 30 focus groups with community-based treatment providers throughout California and directed focus groups with county stakeholders as part of the Substance Abuse and Crime Prevention Act (SACPA) Evaluation in California. Dr. Teruya has experience examining organizational change issues in public institutions and helping groups manage and deal with change in the corporate setting through workshops, teambuilding activities, and consultation. She has been conducting research at UCLA ISAP since 1999.

Education and Training

  • University of California, Los Angeles, B.A., 1979, Psychology
  • University of California, Los Angeles, M.A., 1995, Education
  • University of California, Los Angeles, Ph.D., 1999, Education

Contact Info

UCLA Integrated Substance Abuse Programs
11075 Santa Monica Blvd., Suite 100
Los Angeles, CA 90025
cteruya@ucla.edu

Selected Publications

  • Hser, Y., Huang, D., Teruya, C., & Anglin, M. D.  (2003).  Gender comparisons of drug abuse treatment outcomes and predictors.  Drug and Alcohol Dependence, 72, 255-264.
  • Hser, Y., Teruya, C., Evans, E., Longshore, D., Grella, C., & Farabee, D.  (2003).  Treating drug-abusing offenders:  Initial findings from a five-county study on the impact of California’s Proposition 36 on the treatment system and patient outcomes.  Evaluation Review, 27(5), 479-505.
  • Hser, Y., Huang, D., Teruya, C., & Anglin, M. D.  (2004).  Diversity of drug abuse treatment utilization patterns and outcomes.  Evaluation and Program Planning, 27(3), 309-319.
  • Hser, Y., Huang, Y., Teruya, C., & Anglin, M.D.  (2004).  Gender differences in treatment outcomes over a three-year period.  Journal of Drug Issues, 34(2), 415-436.
  • Hardy, M., Teruya, C., Longshore, D., & Hser, Y.  (2005).  Initial implementation of California’s Substance Abuse and Crime Prevention Act:  Findings from focus groups in ten counties.  Evaluation and Program Planning, 28, 221-232.
  • Grella, C., Hser, Y., Teruya, C., & Evans, E.  (2005).  How can research-based findings be used to improve practice?  Perspectives from participants in a statewide outcomes monitoring study.  Journal of Drug Issues, 35(3), 469-484.
  • Teruya, C., Hardy, M., Hser, Y., & Evans, E.  (2006).  Implementation of a statewide outcome monitoring system:  Lessons learned from substance abuse treatment provider staff.  Qualitative Health Research, 16, 337-352.
  • Longshore, D., & Teruya, C.  (2006).  Treatment motivation in drug users:  A theory-based analysis.  Drug and Alcohol Dependence, 81, 179-188.
  • Hser, Y., Teruya, C., Brown, A. H., Huang, D., Evans, E., & Anglin, M.D.  (2007).  Impact of California’s Proposition 36 on the drug treatment system:  Treatment capacity and displacement.  American Journal of Public Health, 97(1), 104-109.
  • Teruya, C., Longshore, D., Andersen, R. M., Arangua, L., Nyamathi, A., Leake, B., & Gelberg, L.  (2010). Health and health care disparities among homeless women.  Women & Health, 50(8): 719-36.
  • Teruya, C., & Hser, Y. (2010). Turning points in the life course:  Current findings and future directions in drug use research.  Current Drug Abuse Reviews, 3(3),189-95.  PMCID: PMC3010246.
Last updated - 11/04/2011

Click here to view other profiles.

Top of Page